Information:
Fel:
ID
15193
Beskrivning
DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT02312427
Länk
https://clinicaltrials.gov/show/NCT02312427
Nyckelord
Versioner (1)
- 2016-05-22 2016-05-22 -
Uppladdad den
22 maj 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Heart Failure NCT02312427
Eligibility Heart Failure NCT02312427
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT02312427
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Diabetes Mellitus, Non-Insulin-Dependent | Congestive heart failure | Therapeutic procedure Dipeptidyl Peptidase-4 Inhibitor | sitagliptin | vildagliptin | alogliptin | Linagliptin | teneligliptin | anagliptin | saxagliptin
Item
type 2 diabetes patient with congestive heart failure under treatment with dpp-4 inhibitor (sitagliptin, vildagliptin, alogliptin, linagliptin, teneligliptin, anagliptin or saxagliptin) .
boolean
C0011860 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C3537225 (UMLS CUI [3,2])
C1565750 (UMLS CUI [4])
C1570906 (UMLS CUI [5])
C1958126 (UMLS CUI [6])
C2746078 (UMLS CUI [7])
C2981308 (UMLS CUI [8])
C3272640 (UMLS CUI [9])
C1611934 (UMLS CUI [10])
C0018802 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C3537225 (UMLS CUI [3,2])
C1565750 (UMLS CUI [4])
C1570906 (UMLS CUI [5])
C1958126 (UMLS CUI [6])
C2746078 (UMLS CUI [7])
C2981308 (UMLS CUI [8])
C3272640 (UMLS CUI [9])
C1611934 (UMLS CUI [10])
B-type natriuretic peptide (BNP) High
Item
high serum bnp (100-2000pg/ml).
boolean
C2082356 (UMLS CUI [1,1])
C0205250 (UMLS CUI [1,2])
C0205250 (UMLS CUI [1,2])
Informed Consent
Item
patients who have given informed consent to participation in the study.
boolean
C0021430 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c over 9.0%.
boolean
C0019018 (UMLS CUI [1])
Change of medication Before Inclusion
Item
patients who changed medication within 1 months before inclusion.
boolean
C0580105 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,3])
Ineligibility Judgment Clinical Investigators
Item
judged as ineligible by clinical investigators.
boolean
C1512714 (UMLS CUI [1,1])
C0022423 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])
Hospitalization Arm
Item
hospitalization arm
boolean
C0019993 (UMLS CUI [1,1])
C1522541 (UMLS CUI [1,2])
C1522541 (UMLS CUI [1,2])
Diabetes Mellitus, Non-Insulin-Dependent | Hospitalization Congestive heart failure
Item
type 2 diabetes patient who were hospitalized for congestive heart failure.
boolean
C0011860 (UMLS CUI [1])
C0019993 (UMLS CUI [2,1])
C0018802 (UMLS CUI [2,2])
C0019993 (UMLS CUI [2,1])
C0018802 (UMLS CUI [2,2])
Informed consent
Item
patients who have given informed consent to participation in the study.
boolean
C0021430 (UMLS CUI [1])
Insulin regime
Item
patients on insulin therapy.
boolean
C0557978 (UMLS CUI [1])
Ineligibility Judgment Clinical Investigators
Item
judged as ineligible by clinical investigators.
boolean
C1512714 (UMLS CUI [1,1])
C0022423 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])